{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:23:11Z","timestamp":1762820591652,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jacbts.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T14:15:36Z","timestamp":1509372936000},"page":"529-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Matrix Signaling Subsequent to a\u00a0Myocardial Infarction"],"prefix":"10.1016","volume":"2","author":[{"given":"Derrick","family":"Akpalu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gale","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Quarshie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ofili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Fonger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nic","family":"Chronos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2017.04.004_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2741\/S359","article-title":"Role of innate immunity in cardiac inflammation after myocardial infarction","volume":"5","author":"Liaudet","year":"2013","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.jacbts.2017.04.004_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.disamonth.2012.12.004","article-title":"Acute myocardial infarction","volume":"59","author":"Boateng","year":"2013","journal-title":"Dis Mon"},{"key":"10.1016\/j.jacbts.2017.04.004_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yjmcc.2010.12.021","article-title":"Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction","volume":"50","author":"Vilahur","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1527-5299.2003.01446.x","article-title":"Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol","volume":"9","author":"Maack","year":"2003","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacbts.2017.04.004_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10741-008-9094-x","article-title":"Beta-blocker pharmacogenetics in heart failure","volume":"15","author":"Shin","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2017.04.004_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/heartjnl-2014-306835","article-title":"Cardiac resynchronisation therapy in patients with chronic heart failure","volume":"101","author":"Lalani","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2017.04.004_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11897-009-0034-4","article-title":"Prevention of late postmyocardial infarction left ventricular remodeling: an update","volume":"6","author":"Mookadam","year":"2009","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacbts.2017.04.004_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI4985","article-title":"In\u00a0vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant","volume":"104","author":"Combes","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2017.04.004_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2011.06.005","article-title":"Microparticles: targets and tools in cardiovascular disease","volume":"32","author":"Martinez","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2017.04.004_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0003-4509(07)90020-6","article-title":"Markers of thrombotic disease: procoagulant microparticles [in French]","volume":"65","author":"Morel","year":"2007","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.jacbts.2017.04.004_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.04.004_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCRESAHA.110.233049","article-title":"Microparticles in angiogenesis: therapeutic potential","volume":"109","author":"Martinez","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2017.04.004_bib13","first-page":"140","article-title":"The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases","volume":"26","author":"Puddu","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib14","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1002\/pmic.200800109","article-title":"Proteomic profiling of exosomes: current perspectives","volume":"8","author":"Simpson","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jacbts.2017.04.004_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood.V89.4.1121","article-title":"Pathophysiologic implications of membrane phospholipid asymmetry in blood cells","volume":"89","author":"Zwaal","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2017.04.004_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.trsl.2012.01.003","article-title":"Developing and assessing cardiovascular biomarkers","volume":"159","author":"Dadu","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.jacbts.2017.04.004_bib17","first-page":"226","article-title":"Microparticles and cardiovascular disease","volume":"98","author":"Morel","year":"2005","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.jacbts.2017.04.004_bib18","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/j.1538-7836.2010.04007.x","article-title":"Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis","volume":"8","author":"Shantsila","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacbts.2017.04.004_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/ATVBAHA.109.200998","article-title":"Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?","volume":"31","author":"Tushuizen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jash.2012.06.003","article-title":"Microparticles in cardiovascular disease pathophysiology and outcomes","volume":"6","author":"Viera","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacbts.2017.04.004_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.200706-840OC","article-title":"Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension","volume":"177","author":"Bakouboula","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacbts.2017.04.004_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2014.07.008","article-title":"Spatial and temporal organization of signaling pathways","volume":"39","author":"Housden","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jacbts.2017.04.004_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.carrev.2005.07.006","article-title":"A\u00a0clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials","volume":"6","author":"Cui","year":"2005","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacbts.2017.04.004_bib24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.lfs.2007.08.022","article-title":"Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy","volume":"81","author":"Nishijima","year":"2007","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jacbts.2017.04.004_bib25","doi-asserted-by":"crossref","first-page":"I90","DOI":"10.1007\/s003950070016","article-title":"MERIT-HF: description of the trial","volume":"95","author":"Wikstrand","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib26","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/pmic.201400515","article-title":"FunRich: An open access standalone functional enrichment and interaction network analysis tool","volume":"15","author":"Pathan","year":"2015","journal-title":"Proteomics"},{"unstructured":"FunRich: Functional Enrichment Analysis Tool. Available at: http:\/\/funrich.org\/index.html. Accessed April 1, 2016.","key":"10.1016\/j.jacbts.2017.04.004_bib27"},{"key":"10.1016\/j.jacbts.2017.04.004_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12015-006-0015-x","article-title":"Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis","volume":"2","author":"Park","year":"2006","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jacbts.2017.04.004_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tibtech.2016.09.007","article-title":"Human endothelial cell models in biomaterial research","volume":"35","author":"Hauser","year":"2017","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11892-011-0182-2","article-title":"Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis","volume":"11","author":"Onat","year":"2011","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacbts.2017.04.004_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fphys.2013.00323","article-title":"New advances in beta-blocker therapy in heart failure","volume":"4","author":"Barrese","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2165\/00003495-200060030-00011","article-title":"Metoprolol: a review of its use in chronic heart failure","volume":"60","author":"Prakash","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jacbts.2017.04.004_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jacbts.2017.04.004_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","article-title":"The fibrosis-cell death axis in heart failure","volume":"21","author":"Piek","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2017.04.004_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/wsbm.1248","article-title":"Using systems biology approaches to understand cardiac inflammation and extracellular matrix remodeling in the setting of myocardial infarction","volume":"6","author":"Ghasemi","year":"2014","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.jacbts.2017.04.004_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacbts.2017.04.004_bib37","first-page":"380","article-title":"Postinfarction cardiac remodeling: clinical consequences [in Polish]","volume":"66","author":"Karpinski","year":"2009","journal-title":"Przegl Lek"},{"key":"10.1016\/j.jacbts.2017.04.004_bib38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.bjc.6603642","article-title":"The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome","volume":"96","author":"Kumar","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jacbts.2017.04.004_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/157340309787048068","article-title":"Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart","volume":"5","author":"Kishimoto","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jacbts.2017.04.004_bib40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.0000029923.57048.61","article-title":"Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2017.04.004_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.HYP.0000173420.31354.ef","article-title":"Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice","volume":"46","author":"Nakanishi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2017.04.004_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cvr\/cvr106","article-title":"\u03b2-adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines","volume":"91","author":"George","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2017.04.004_bib43","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2012-2132","article-title":"Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice","volume":"154","author":"Mao","year":"2013","journal-title":"Endocrinology"},{"issue":"Suppl","key":"10.1016\/j.jacbts.2017.04.004_bib44","first-page":"S141","article-title":"The induction of Hsp70 by beta blockade in the human aorta during coronary artery bypass grafting (CABG) or replacement of an ascending thoracic aortic aneurysm (ATAA) is associated with less apoptosis","author":"Tsoporis","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00424-004-1332-z","article-title":"Heat shock protein 70 inhibits shrinkage-induced programmed cell death via mechanisms independent of effects on cell volume-regulatory membrane transport proteins","volume":"449","author":"Nylandsted","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacbts.2017.04.004_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s003950070039","article-title":"Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70","volume":"95","author":"Suzuki","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.07.042","article-title":"Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3","volume":"595","author":"Sharma","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/eci.12598","article-title":"\u03b2-adrenergic receptor signalling and its functional consequences in the diseased heart","volume":"46","author":"Najafi","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacbts.2017.04.004_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2010.11.007","article-title":"The role of beta-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection","volume":"31","author":"Bernstein","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138161282104141204124129","article-title":"Targeting cardiomyocyte Ca2+ homeostasis in heart failure","volume":"21","author":"Roe","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"Pt 2","key":"10.1016\/j.jacbts.2017.04.004_bib51","first-page":"H474","article-title":"Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban","volume":"277","author":"Schmidt","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0735-1097(97)00248-9","article-title":"Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure","volume":"30","author":"B\u00f6hm","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2017.04.004_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fphys.2013.00264","article-title":"Targeting cardiac \u03b2-adrenergic signaling via GRK2 inhibition for heart failure therapy","volume":"4","author":"Cannavo","year":"2013","journal-title":"Front Physiol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X17301985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X17301985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:18:36Z","timestamp":1762820316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X17301985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2452302X17301985"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2017.04.004","relation":{},"ISSN":["2452-302X"],"issn-type":[{"type":"print","value":"2452-302X"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix Signaling Subsequent to a\u00a0Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier on behalf of American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}